Neonatal SeizureMeerkatNCT04831242
Monitoring Key Activity and Physiology of Neonates in Intensive Care
An observational study of Neonatal Seizure, run by Cambridge University Hospitals NHS Foundation Trust at 1 site in United Kingdom.
Trial summary
To optimise and evaluate a novel non-contact physiological monitoring system in the neonatal intensive care unit (NICU) Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Neonatal Seizure
- How many people
- 48 participants
- Where
- 1 siteUnited Kingdom
- Study dates
- 1 Aug 2021to 31 Dec 2026
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: Newborn infants in neonatal intensive care
Who may be able to join
- written informed parental consent
Who cannot join
- -
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United Kingdom1 site, 1 recruiting
- Recruiting
Addenbrookes Hospital
Cambridge
Lynn Thomson, 07565964631, lynn.thomson12@nhs.net
About this study
To optimise and evaluate a novel non-contact physiological monitoring system in the neonatal intensive care unit (NICU)
Read the detailed description
To optimise and evaluate a novel non-contact physiological monitoring system in the neonatal intensive care unit (NICU)
- Conditions
- Neonatal Seizure
What is being measured
The primary outcome is the main question the study is designed to answer.
Movement
cm
Measured: First week of life
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 Apr 2021
- Study start1 Aug 2021
- Primary completion30 Dec 2026 (estimated)
- Study completion31 Dec 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Neonatal SeizureStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 48 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Cambridge University Hospitals NHS Foundation Trust
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Kathryn Beardsall, Cambridge University Hospitals NHS Foundation Trust
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04831242
- Sponsor's protocol ID
- Meerkat vs 1.0 1st Feb 2021
- Acronym
- Meerkat
- Status last verified
- Apr 2025
- First submitted
- 1 Apr 2021
- Last updated
- 18 Apr 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Publications
Grafton A, Thomson L, Beardsall K, Lasenby J. Camera-based respiratory rate monitoring in unmodified neonatal intensive care - a cross-sectional study in a UK hospital. EClinicalMedicine. 2026 Aug 31;99:104175. doi: 10.1016/j.eclinm.2026.104175. eCollection 2026 Sep.
PubMed 42729653
Study at a glance
From the registry record, last updated by the sponsor on 18 Apr 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Monitoring Key Activity and Physiology of Neonates in Intensive Care
- ClinicalTrials.gov ID
- NCT04831242
- Acronym / sponsor ID
- Meerkat / Meerkat vs 1.0 1st Feb 2021
- Conditions
- Neonatal Seizure
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 48 participants (estimated)
- Lead sponsor
- Cambridge University Hospitals NHS Foundation TrustUniversity, hospital or other
- Study start
- 1 Aug 2021 (actual)
- Primary completion
- 30 Dec 2026 (estimated)
- Study completion
- 31 Dec 2026 (estimated)
- First posted
- 5 Apr 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
To optimise and evaluate a novel non-contact physiological monitoring system in the neonatal intensive care unit (NICU)
Detailed description
To optimise and evaluate a novel non-contact physiological monitoring system in the neonatal intensive care unit (NICU)
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- Newborn infants in neonatal intensive care
Key inclusion criteria (1 listed)
- written informed parental consent
Key exclusion criteria (1 listed)
- -
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Movement
Time frame: First week of life
cm
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 18 Apr 2025.
- Derived from this study: PubMed 42729653Grafton A, Thomson L, Beardsall K, Lasenby J. Camera-based respiratory rate monitoring in unmodified neonatal intensive care - a cross-sectional study in a UK hospital. EClinicalMedicine. 2026 Aug 31;99:104175. doi: 10.1016/j.eclinm.2026.104175. eCollection 2026 Sep.
Related trials for Neonatal Seizure
RecruitingPhase 3
Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults
Seizures, Lennox Gastaut Syndrome
Not yet recruitingPhase 4
Study of Electrocardiogram (ECG) Safety of Sezaby in Neonatal Seizures
Neonatal Seizure
RecruitingObservational study
Genetic Markers of Cardiovascular Disease in Epilepsy
Epilepsy, Seizures
Recruiting
FITting Non-invasive Tests in Lynch Syndrome Surveillance
Colorectal Cancer
RecruitingPhase 2
A Dose Escalation Study of Levetiracetam in the Treatment of Neonatal Seizures
Neonatal Seizure, Neonatal Encephalopathy
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Neonatal Seizure, run by Cambridge University Hospitals NHS Foundation Trust at 1 site in United Kingdom.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 18 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact kathryn beardsall (01223 746791, kb274@cam.ac.uk), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Movement (time frame: First week of life). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT04831242, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Apr 2025.